Boothbay Fund Management, LLC A Tyr Pharma Inc Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.72 - $2.57 $75,680 - $113,080	-44,000 Reduced 55.0%	36,000 $77,000
Q1 2023 May 15, 2023	BUY	$1.88 - $2.5 $150,400 - $200,000	80,000 New	80,000 $168,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $410,638 - $535,125	-56,329 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $100,853 - $298,259	23,899 Added 73.69%	56,329 $511,000
Q1 2021 May 17, 2021	SELL	$3.53 - $8.06 $32,652 - $74,555	-9,250 Reduced 22.19%	32,430 $144,000
Q4 2020 Feb 12, 2021	BUY	$3.07 - $4.66 $127,957 - $194,228	41,680 New	41,680 $162,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.